Cargando…

Structural brain volume differences between cognitively intact ApoE4 carriers and non-carriers across the lifespan

Apolipoprotein E4 (ApoE4) is a prominent genetic risk factor for Alzheimer's disease. The purpose of this review is to explore differences in structural brain volume detected by magnetic resonance imaging between cognitively intact ApoE4 carriers and non-carriers across the lifespan (i.e., olde...

Descripción completa

Detalles Bibliográficos
Autor principal:	Piers, Ryan J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6108197/ https://www.ncbi.nlm.nih.gov/pubmed/30106031 http://dx.doi.org/10.4103/1673-5374.235408

Ejemplares similares

Increased hippocampal activation in ApoE-4 carriers and non-carriers with amnestic mild cognitive impairment
por: Tran, Tammy T., et al.
Publicado: (2016)

Higher Brain Perfusion May Not Support Memory Functions in Cognitively Normal Carriers of the ApoE ε4 Allele Compared to Non-Carriers
por: Zlatar, Zvinka Z., et al.
Publicado: (2016)

Reduced Hippocampal Volume in Healthy Young ApoE4 Carriers: An MRI Study
por: O'Dwyer, Laurence, et al.
Publicado: (2012)

Mitochondrial Pyruvate Carrier Function in Health and Disease across the Lifespan
por: Buchanan, Jane L., et al.
Publicado: (2020)

THE COMPARISON OF DUAL TASK TIME AMONG APOE CARRIERS AGAINST NON-APOE CARRIERS IN AGING ADULTS
por: Diehl, Cody, et al.
Publicado: (2022)

Anxiety correlates with cortical surface area in subjective cognitive decline: APOE ε4 carriers versus APOE ε4 non-carriers
por: Sun, Yu, et al.
Publicado: (2019)

Longitudinal changes in (18)F-Flutemetamol amyloid load in cognitively intact APOE4 carriers versus noncarriers: Methodological considerations
por: Luckett, Emma S., et al.
Publicado: (2023)

A Systems View of the Differences between APOE ε4 Carriers and Non-carriers in Alzheimer’s Disease
por: Jiang, Shan, et al.
Publicado: (2016)

White Matter Differences between Healthy Young ApoE4 Carriers and Non-Carriers Identified with Tractography and Support Vector Machines
por: O'Dwyer, Laurence, et al.
Publicado: (2012)

Precision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers
por: Norwitz, Nicholas G., et al.
Publicado: (2021)

Lower mortality risk in APOE4 carriers with normal cognitive ageing
por: Pirraglia, Elizabeth, et al.
Publicado: (2023)

Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers()
por: Adamczuk, Katarzyna, et al.
Publicado: (2013)

Role of apolipoprotein E epsilon 4 (APOE*ε4) as an independent risk factor for incident depression over a 12-year period in cognitively intact adults across the lifespan
por: Burns, Richard Andrew, et al.
Publicado: (2020)

Superior short-term memory in APOE ε2 carriers across the age range
por: Zokaei, Nahid, et al.
Publicado: (2021)

A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke
por: Eyford, Brett A., et al.
Publicado: (2021)

Differences in resting-state brain networks and gray matter between APOE ε2 and APOE ε4 carriers in non-dementia elderly
por: Wang, Zhiyuan, et al.
Publicado: (2023)

Associations Between Sub-Threshold Amyloid-β Deposition, Cortical Volume, and Cognitive Function Modulated by APOE ɛ4 Carrier Status in Cognitively Normal Older Adults
por: Kang, Dong Woo, et al.
Publicado: (2022)

Amyloid deposition and ApoE4 carriers in idiopathic normal pressure hydrocephalus
por: Bundo, Masahiko, et al.
Publicado: (2015)

APOE-ɛ4 Carrier Status and Donepezil Response in Patients with Alzheimer’s Disease
por: Waring, Jeffrey F., et al.
Publicado: (2015)

Vascular Dysfunction Is Central to Alzheimer’s Disease Pathogenesis in APOE e4 Carriers
por: McCorkindale, Andrew N., et al.
Publicado: (2022)

No differences in brain microstructure between young KIBRA-C carriers and non-carriers
por: Hu, Li, et al.
Publicado: (2017)

The APOE ε4 Allele Affects Cognitive Functions Differently in Carriers of APP Mutations Compared to Carriers of PSEN1 Mutations in Autosomal-Dominant Alzheimer’s Disease
por: Almkvist, Ove, et al.
Publicado: (2021)

A Triple Network Connectivity Study of Large-Scale Brain Systems in Cognitively Normal APOE4 Carriers
por: Wu, Xia, et al.
Publicado: (2016)

Learning deficit in cognitively normal APOE ε4 carriers with LOW β‐amyloid
por: Lim, Yen Ying, et al.
Publicado: (2021)

Plasma Apolipoprotein E3 and Glucose Levels Are Associated in APOE ɛ3/ɛ4 Carriers
por: Edlund, Anna K., et al.
Publicado: (2021)

Corrigendum: A Nanomule Peptide Carrier Delivers siRNA Across the Intact Blood-Brain Barrier to Attenuate Ischemic Stroke
por: Eyford, Brett A., et al.
Publicado: (2021)

Sphingolipids in Cerebrospinal Fluid and Plasma Lipoproteins of APOE4 Homozygotes and Non-APOE4 Carriers with Mild Cognitive Impairment versus Subjective Cognitive Decline
por: den Hoedt, Sandra, et al.
Publicado: (2023)

Oscillatory hyperactivity and hyperconnectivity in young APOE-ɛ4 carriers and hypoconnectivity in Alzheimer’s disease
por: Koelewijn, Loes, et al.
Publicado: (2019)

Platelet cytochrome oxidase and citrate synthase activities in APOE ε4 carrier and non-carrier Alzheimer's disease patients
por: Wilkins, Heather M., et al.
Publicado: (2017)

Sex and APOE: A memory advantage in male APOE ε4 carriers in midlife
por: Zokaei, Nahid, et al.
Publicado: (2017)

Tract-specific differences in white matter microstructure between young adult APOE ε4 carriers and non-carriers: A replication and extension study
por: Lissaman, Rikki, et al.
Publicado: (2022)

Loss of Lipid Carrier ApoE Exacerbates Brain Glial and Inflammatory Responses after Lysosomal GBA1 Inhibition
por: Connolly, Kyle J., et al.
Publicado: (2023)

Identification of epigenome-wide DNA methylation differences between carriers of APOE ε4 and APOE ε2 alleles
por: Walker, Rosie M., et al.
Publicado: (2021)

Association of Homocysteine Levels With Medial Temporal Lobe Atrophy Among Carriers and Non-carriers of APOE ε4 in MCI Subjects
por: Ma, Jun, et al.
Publicado: (2022)

mTOR: Alzheimer's disease prevention for APOE4 carriers
por: Lin, Ai-Ling, et al.
Publicado: (2016)

Impaired memory-guided attention in asymptomatic APOE4 carriers
por: Zimmermann, Jacqueline, et al.
Publicado: (2019)

Association of Chronic Low-grade Inflammation With Risk of Alzheimer Disease in ApoE4 Carriers
por: Tao, Qiushan, et al.
Publicado: (2018)

Accelerated long‐term forgetting over three months in asymptomatic APOE ɛ4 carriers
por: Tort‐Merino, Adrià, et al.
Publicado: (2020)

The Effects of rs405509 on APOEε4 Non-carriers in Non-demented Aging
por: Wu, Dongpeng, et al.
Publicado: (2021)

The Association of Depressive Symptoms With Brain Volume Is Stronger Among Diabetic Elderly Carriers of the Haptoglobin 1-1 Genotype Compared to Non-carriers
por: Livny, Abigail, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_jdbk13697ng5olq2lvkc1ai997